Trial intelligence / Profile preview

Propofol and Remifentanil vs Midazolam and Remifentanil for RDS Premedication

NCT00797160Phase 4Unknown

Sponsor
Universidade Federal de Minas Gerais
Start
Aug 2008
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of propofol injection (veterinary) in respiratory distress syndrome (RDS), sponsored by Universidade Federal de Minas Gerais. Primary endpoint: Time until extubation after bolus dose at 3 days. Status: unknown.

02

Drugs

propofol injection (veterinary)
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on NCT00797160.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00797160.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call